Anti-COVID drug accelerates viral evolution

Sergei L. Kosakovsky Pond () and Darren Martin ()

Nature, 2023, vol. 623, issue 7987, 486-487

Abstract: Molnupiravir, an antiviral drug used to treat COVID-19, induces numerous mutations in the SARS-CoV-2 genome that can increase the rate at which the virus evolves — yielding viral variants that might survive and be passed on.

Keywords: SARS-CoV-2; Virology; Genomics (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/d41586-023-03248-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:623:y:2023:i:7987:d:10.1038_d41586-023-03248-3

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-023-03248-3

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().